Meritain Health policies, page 9

Search Meritain Health's public medical, payment and drug policies by CPT or HCPCS code, keyword or policy number, with links to the payer's own documents. Links open the payer's own document; check its current version before relying on it.

5,481 public policies Substrate tracks for Meritain Health, by title.

Meritain Health policies
PolicyDetailsCodesSource
1001-Sirolimus Protein-Bound Particles for Injectable Suspension Albumin-Bound (Fyarro)1001 · Commercial7Original policy ↗
1002-Efgartigimod Alfa-fcab (Vyvgart) and Efgartigimod Alfa and Hyaluronidase-qvfc (Vyvgart Hytrulo)1002 · Commercial42Original policy ↗
1003-Tezepelumab-ekko (Tezspire)1003 · Commercial64Original policy ↗
1004-Inclisiran (Leqvio)1004 · Commercial11Original policy ↗
1005-Tebentafusp-tebn (Kimmtrak)1005 · Commercial5Original policy ↗
1006-Sutimlimab-jome (Enjaymo)1006 · Commercial17Original policy ↗
1007-Ciltacabtagene Autoleucel (Carvykti)1007 · Commercial15Original policy ↗
1008-Infectious Diseases: Selected Tests1008 · Commercial30Original policy ↗
1009-Risankizumab-rzaa (Skyrizi)1009 · Commercial66Original policy ↗
1010-Dengue Vaccine1010 · Commercial, Medicaid13Original policy ↗
1011-Guselkumab (Tremfya)1011 · Commercial37Original policy ↗
1012-Tildrakizumab-asmn (Ilumya)1012 · Commercial35Original policy ↗
1013-Spesolimab-sbzo (Spevigo)1013 · Commercial28Original policy ↗
1014-Testosterone Cypionate Injections1014 · Commercial7Original policy ↗
1015-Testosterone Enanthate Injection1015 · Commercial6Original policy ↗
1017-Elivaldogene Autotemcel (Skysona)1017 · Commercial44Original policy ↗
1018-Teclistamab-cqyv (Tecvayli)1018 · Commercial17Original policy ↗
1019-Tremelimumab-actl (Imjudo)1019 · Commercial10Original policy ↗
1020-Sodium Thiosulfate (Pedmark)1020 · Commercial3Original policy ↗
1021-Mirvetuximab Soravtansine-gynx (Elahere)1021 · Commercial10Original policy ↗
1022-Teplizumab-mzwv (Tzield)1022 · Commercial16Original policy ↗
1023-Etranacogene Dezaparvovec-drlb (Hemgenix)1023 · Commercial41Original policy ↗
1024-Nadofaragene Firadenovec-vncg (Adstiladrin)1024 · Commercial4Original policy ↗
1025-Mosunetuzumab-axgb (Lunsumio and Lunsumio Velo)1025 · Commercial5Original policy ↗
1026-Lecanemab-irmb (Leqembi)1026 · Commercial21Original policy ↗
1027-Respiratory Syncytial Virus (RSV) Vaccines for Adult and Maternal Use1027 · Commercial9Original policy ↗
1028-Difelikefalin (Korsuva) Injection1028 · Commercial3Original policy ↗
1029-Pegcetacoplan Intravitreal Injection (Syfovre)1029 · Commercial2Original policy ↗
1031-Tofersen (Qalsody)1031 · Commercial6Original policy ↗
1032-Omidubicel-onlv (Omisirge)1032 · Commercial9Original policy ↗
1033-Beremagene Geperpavec-svdt (Vyjuvek)1033 · Commercial10Original policy ↗
1034-Epcoritamab-bysp (Epkinly)1034 · Commercial8Original policy ↗
1035-Rozanolixizumab-noli (Rystiggo)1035 · Commercial28Original policy ↗
1036-Glofitamab-gxbm (Columvi)1036 · Commercial10Original policy ↗
1037-Valoctocogene Roxaparvovec-rvox (Roctavian) - CPB 10361037 · Commercial35Original policy ↗
1038-Nirsevimab-alip (Beyfortus)1038 · Commercial11Original policy ↗
1039-Venous Stenting for the Treatment of Idiopathic Intracranial Hypertension1039 · Commercial53Original policy ↗
1040-Elranatamab-bcmm (Elrexfio)1040 · Commercial10Original policy ↗
1041-Avacincaptad Pegol (Izervay)1041 · Commercial2Original policy ↗
1042-Talquetamab-tgvs (Talvey)1042 · Commercial15Original policy ↗
1043-Pozelimab-bbfg (Veopoz)1043 · Commercial3Original policy ↗
1044-Daprodustat (Jesduvroq)1044 · Commercial3Original policy ↗
1045-Osseointegration for Lower and Upper Limbs1045 · Commercial1Original policy ↗
1047-Nedosiran (Rivfloza)1047 · Commercial12Original policy ↗
1048-Mirikizumab-mrkz (Omvoh)1048 · Commercial15Original policy ↗
1049-Toripalimab-tpzi (Loqtorzi)1049 · Commercial11Original policy ↗
1050-ADAMTS13, Recombinant-krhn (Adzynma)1050 · Commercial6Original policy ↗
1051-Cantharidin (Ycanth)1051 · Commercial3Original policy ↗
1052-Exagamglogene Autotemcel (Casgevy)1052 · Commercial8Original policy ↗
1053-Lovotibeglogene Autotemcel (Lyfgenia)1053 · Commercial8Original policy ↗

Back to Meritain Health

Disclaimer

The information provided on this page is for general informational purposes only and does not constitute billing, coding, or reimbursement advice. Nothing on this page should be relied upon as a substitute for clinician assessment, professional billing guidance, or as a definitive statement of any payor's billing requirements or policies.

Payor agreements, fee schedules, and billing policies vary and are subject to change. Before submitting any claims related to maternity care services, including claims affected by the 2027 CPT code revisions, please consult the applicable payor agreements, coverage policies, and billing guidelines to confirm current requirements for their specific payor contracts.

Substrate makes no representation or warranty regarding the accuracy, completeness, or timeliness of the payor-specific information presented here. Providers are solely responsible for ensuring that all claims are submitted in accordance with applicable payor requirements, and Substrate assumes no liability for claim denials, underpayments, or other adverse outcomes arising from reliance on this information.